cytosine has been researched along with HIV Coinfection in 62 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acyclovir-resistant herpes simplex virus (HSV) infection is common in immunocompromised patients, but the course of such infection is little known." | 7.80 | Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection. ( Agut, H; Boutolleau, D; Burrel, S; Caumes, E; Epelboin, L; Katlama, C; Regnier, S; Seang, S; Valantin, MA; Voujon, D, 2014) |
| "The use of the acyclic nucleoside phosphonates, starting with (S)-HPMPA as the prototype, yielded three clinically approved antiviral drugs, cidofovir for the treatment of CMV retinitis in AIDS patients, adefovir dipivoxil for the treatment of chronic hepatitis B and tenofovir disoproxil fumarate for the treatment of HIV infections (AIDS) and HBV infections." | 4.87 | The clinical potential of the acyclic (and cyclic) nucleoside phosphonates: the magic of the phosphonate bond. ( De Clercq, E, 2011) |
| "A new homogeneous electrochemical sensing strategy based on exonuclease III-assisted target recycling amplification was utilized for simple, rapid and highly sensitive detection of human immunodeficiency virus (HIV) DNA on an immobilization-free Ag(I)-assisted hairpin DNA through the cytosine-Ag(+)-cytosine coordination chemistry." | 3.81 | Exonuclease III-based target recycling for ultrasensitive homogeneous monitoring of HIV DNA using Ag(+)-coordinated hairpin probe. ( Deng, K; Fu, WL; Sun, AL, 2015) |
| "Acyclovir-resistant herpes simplex virus (HSV) infection is common in immunocompromised patients, but the course of such infection is little known." | 3.80 | Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection. ( Agut, H; Boutolleau, D; Burrel, S; Caumes, E; Epelboin, L; Katlama, C; Regnier, S; Seang, S; Valantin, MA; Voujon, D, 2014) |
| " After intravenous administration of cyclic HPMPC, concentrations of cyclic HPMPC declined in a biexponential manner, with a mean +/- standard deviation half-life of 1." | 2.69 | Clinical pharmacokinetics of 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine in human immunodeficiency virus-infected patients. ( Barditch-Crovo, P; Cundy, KC; Jaffe, HS; Lietman, PS; Petty, BG; Redpath, M; Ruby, A, 1999) |
| " Nephrotoxicity in one subject was the only serious adverse event observed." | 2.68 | Pharmacokinetics, safety and bioavailability of HPMPC (cidofovir) in human immunodeficiency virus-infected subjects. ( Cundy, KC; Fisher, PE; Jaffe, HS; Lietman, PS; Pastelak, A; Petty, BG; Wachsman, M, 1996) |
| "Almost all cases were treated with vaccinia immune globulin, but its efficacy has never been tested in a placebo-controlled trial." | 2.42 | Progressive vaccinia. ( Bray, M; Wright, ME, 2003) |
| "CMV-related retinal detachment is treated surgically." | 2.40 | Cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. ( Au Eong, KG; Beatty, S; Charles, SJ, 1999) |
| "Pure alexia, or alexia without agraphia, is usually caused by disconnection between the gyrus angularis and visual areas of both hemispheres." | 1.33 | [Pure alexia secondary to progressive multifocal leukoencephalopathy as first manifestation of HIV infection]. ( Cobo, J; Corral, I; García, AM; Quereda, C, 2006) |
| "Progressive multifocal leukoencephalopathy is an infectious demyelinating brain disease caused by the JC virus that is associated with significant morbidity and mortality in the immunocompromised host." | 1.32 | Progressive multifocal leukoencephalopathy successfully treated with highly active antiretroviral therapy and cidofovir in an adolescent infected with perinatal human immunodeficiency virus (HIV). ( Abrams, EJ; Ainyette, I; Champion, SE; Chiriboga, CA; DiGrado, M; Robinson, LG, 2004) |
| "0 mg/kg of body weight and declined biexponentially with an overall mean +/- standard deviation terminal half-life of 2." | 1.29 | Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients. ( Cundy, KC; Fisher, PE; Flaherty, J; Hitchcock, MJ; Jaffe, HS; Lalezari, JP; Lietman, PS; Petty, BG; Polis, MA; Wachsman, M, 1995) |
| " Efficacy trials with CMV disease will define the therapeutic utility and optimal dosing interval for cidofovir." | 1.29 | Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria. ( Baird, BF; Davey, RT; Falloon, J; Fisher, PE; Jaffe, HS; Kovacs, JA; Manischewitz, JF; Polis, MA; Spooner, KM; Walker, RE, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 16 (25.81) | 18.2507 |
| 2000's | 30 (48.39) | 29.6817 |
| 2010's | 14 (22.58) | 24.3611 |
| 2020's | 2 (3.23) | 2.80 |
| Authors | Studies |
|---|---|
| Stafford, A | 1 |
| Rimmer, S | 1 |
| Gilchrist, M | 1 |
| Sun, K | 1 |
| Davies, EP | 1 |
| Waddington, CS | 1 |
| Chiu, C | 1 |
| Armstrong-James, D | 1 |
| Swaine, T | 1 |
| Davies, F | 1 |
| Gómez, CHM | 1 |
| Kumar, V | 1 |
| ElHaddad, A | 1 |
| Awad, Z | 1 |
| Smart, C | 1 |
| Mora-Peris, B | 1 |
| Muir, D | 1 |
| Randell, P | 1 |
| Peters, J | 1 |
| Chand, M | 1 |
| Warrell, CE | 1 |
| Rampling, T | 1 |
| Cooke, G | 1 |
| Dhanji, S | 1 |
| Campbell, V | 1 |
| Davies, C | 1 |
| Osman, S | 1 |
| Abbara, A | 1 |
| Geant, PY | 1 |
| Uttaro, JP | 1 |
| Périgaud, C | 1 |
| Mathé, C | 1 |
| Derache, A | 1 |
| Iwuji, CC | 1 |
| Danaviah, S | 1 |
| Giandhari, J | 1 |
| Marcelin, AG | 1 |
| Calvez, V | 1 |
| de Oliveira, T | 1 |
| Dabis, F | 1 |
| Pillay, D | 1 |
| Gupta, RK | 1 |
| Ciarrocca, K | 1 |
| Jackson, LL | 1 |
| De Rossi, SS | 1 |
| Wanat, KA | 1 |
| Gormley, RH | 1 |
| Rosenbach, M | 1 |
| Kovarik, CL | 1 |
| Seang, S | 1 |
| Boutolleau, D | 2 |
| Burrel, S | 1 |
| Regnier, S | 2 |
| Epelboin, L | 1 |
| Voujon, D | 1 |
| Valantin, MA | 1 |
| Katlama, C | 2 |
| Agut, H | 2 |
| Caumes, E | 1 |
| Sun, AL | 1 |
| Deng, K | 1 |
| Fu, WL | 1 |
| Loignon, M | 1 |
| Toma, E | 1 |
| Sendagorta, E | 1 |
| Bernardino, JI | 1 |
| Álvarez-Gallego, M | 1 |
| Feíto, M | 1 |
| Feltes, R | 1 |
| Beato, MJ | 1 |
| Pérez-Molina, JA | 1 |
| Yllescas, M | 1 |
| Díaz-Almirón, M | 1 |
| Arribas, JR | 1 |
| González-García, J | 1 |
| Herranz, P | 1 |
| De Socio, GV | 1 |
| Simonetti, S | 1 |
| Rosignoli, D | 1 |
| Minga, P | 1 |
| Tomassini, GM | 1 |
| Baldelli, F | 1 |
| Collette, DC | 1 |
| Zechel, MA | 1 |
| Erickson, C | 1 |
| Driscoll, M | 1 |
| Gaspari, A | 1 |
| De Clercq, E | 3 |
| Ellis, RM | 1 |
| Mohr, MR | 1 |
| Oldfield, EC | 1 |
| Hood, AF | 1 |
| Krečmerová, M | 1 |
| Otmar, M | 1 |
| Fox, PA | 1 |
| Nathan, M | 1 |
| Marra, CM | 1 |
| Rajicic, N | 1 |
| Barker, DE | 1 |
| Cohen, BA | 1 |
| Clifford, D | 1 |
| Donovan Post, MJ | 1 |
| Ruiz, A | 1 |
| Bowen, BC | 1 |
| Huang, ML | 1 |
| Queen-Baker, J | 1 |
| Andersen, J | 1 |
| Kelly, S | 1 |
| Shriver, S | 1 |
| Bray, M | 1 |
| Wright, ME | 1 |
| Robinson, LG | 1 |
| Chiriboga, CA | 1 |
| Champion, SE | 1 |
| Ainyette, I | 1 |
| DiGrado, M | 1 |
| Abrams, EJ | 1 |
| DeRossi, SS | 1 |
| Laudenbach, J | 1 |
| Berezne, A | 1 |
| Agbalika, F | 1 |
| Oksenhendler, E | 1 |
| Toutous-Trellu, L | 1 |
| Hirschel, B | 1 |
| Piguet, V | 1 |
| Schiffer, V | 1 |
| Saurat, JH | 1 |
| Pechère, M | 1 |
| Aukrust, P | 1 |
| Luna, L | 1 |
| Ueland, T | 1 |
| Johansen, RF | 1 |
| Müller, F | 1 |
| Frøland, SS | 1 |
| Seeberg, EC | 1 |
| Bjørås, M | 1 |
| Priet, S | 1 |
| Gros, N | 1 |
| Navarro, JM | 1 |
| Boretto, J | 1 |
| Canard, B | 1 |
| Quérat, G | 1 |
| Sire, J | 1 |
| Ortiz, A | 1 |
| Justo, P | 1 |
| Sanz, A | 1 |
| Melero, R | 1 |
| Caramelo, C | 1 |
| Guerrero, MF | 1 |
| Strutz, F | 1 |
| Müller, G | 1 |
| Barat, A | 1 |
| Egido, J | 1 |
| Astriti, M | 1 |
| Zeller, V | 1 |
| Gautheret-Dejean, A | 1 |
| Allen, G | 1 |
| Seilhean, D | 1 |
| Bricaire, F | 1 |
| Bossi, P | 1 |
| Andrei, G | 1 |
| Balzarini, J | 1 |
| Leyssen, P | 1 |
| Naesens, L | 1 |
| Neyts, J | 1 |
| Pannecouque, C | 1 |
| Snoeck, R | 1 |
| Ying, C | 1 |
| Hocková, D | 1 |
| Holý, A | 1 |
| García, AM | 1 |
| Corral, I | 1 |
| Cobo, J | 1 |
| Quereda, C | 1 |
| Ghislanzoni, M | 1 |
| Cusini, M | 1 |
| Zerboni, R | 1 |
| Alessi, E | 1 |
| Drake, AK | 1 |
| Loy, CT | 1 |
| Brew, BJ | 1 |
| Chen, TC | 1 |
| Petoumenos, K | 1 |
| Li, PC | 1 |
| Wright, EJ | 1 |
| Ahlenstiel, G | 1 |
| Nischalke, HD | 1 |
| Bueren, K | 1 |
| Berg, T | 1 |
| Vogel, M | 1 |
| Biermer, M | 1 |
| Grünhage, F | 1 |
| Sauerbruch, T | 1 |
| Rockstroh, J | 1 |
| Spengler, U | 1 |
| Nattermann, J | 1 |
| Shrestha, S | 1 |
| Wang, C | 1 |
| Aissani, B | 1 |
| Wilson, CM | 1 |
| Tang, J | 1 |
| Kaslow, RA | 1 |
| Tejera-Vaquerizo, A | 1 |
| Bosch-García, RJ | 1 |
| Fernández-Orland, A | 1 |
| Herrera-Ceballos, E | 1 |
| Beaulieu, D | 1 |
| Burnouf, M | 1 |
| Plantier, F | 1 |
| Lacau Saint-Guily, J | 1 |
| Avril, MF | 1 |
| Dupin, N | 1 |
| Cundy, KC | 3 |
| Petty, BG | 3 |
| Flaherty, J | 1 |
| Fisher, PE | 3 |
| Polis, MA | 2 |
| Wachsman, M | 2 |
| Lietman, PS | 3 |
| Lalezari, JP | 2 |
| Hitchcock, MJ | 2 |
| Jaffe, HS | 4 |
| Spooner, KM | 1 |
| Baird, BF | 1 |
| Manischewitz, JF | 1 |
| Falloon, J | 1 |
| Davey, RT | 1 |
| Kovacs, JA | 1 |
| Walker, RE | 1 |
| Cherrington, JM | 1 |
| Miner, R | 1 |
| Drew, WL | 1 |
| Pastelak, A | 1 |
| Danner, SA | 1 |
| Meadows, KP | 1 |
| Tyring, SK | 1 |
| Pavia, AT | 1 |
| Rallis, TM | 1 |
| Sadler, M | 1 |
| Chinn, R | 1 |
| Healy, J | 1 |
| Fisher, M | 1 |
| Nelson, MR | 1 |
| Gazzard, BG | 1 |
| Barditch-Crovo, P | 1 |
| Ruby, A | 1 |
| Redpath, M | 1 |
| Jaruga, P | 1 |
| Jaruga, B | 1 |
| Olczak, A | 1 |
| Halota, W | 1 |
| Olinski, R | 1 |
| Au Eong, KG | 1 |
| Beatty, S | 1 |
| Charles, SJ | 1 |
| Portilla, J | 1 |
| Boix, V | 1 |
| Román, F | 1 |
| Reus, S | 1 |
| Merino, E | 1 |
| De Luca, A | 1 |
| Giancola, ML | 1 |
| Ammassari, A | 1 |
| Grisetti, S | 1 |
| Cingolani, A | 1 |
| Paglia, MG | 1 |
| Govoni, A | 1 |
| Murri, R | 1 |
| Testa, L | 1 |
| Monforte, AD | 1 |
| Antinori, A | 1 |
| Kay, TD | 1 |
| Hogan, PG | 1 |
| McLeod, SE | 1 |
| Johnson, DW | 1 |
| Houston, S | 1 |
| Roberts, N | 1 |
| Mashinter, L | 1 |
| Calista, D | 1 |
| Descamps, V | 1 |
| Duval, X | 1 |
| Grossin, M | 1 |
| Crickx, B | 1 |
| Leport, C | 1 |
| Smart, T | 1 |
| Cadman, J | 1 |
| McArthur, J | 1 |
| Matteelli, A | 1 |
| Beltrame, A | 1 |
| Graifemberghi, S | 1 |
| Forleo, MA | 1 |
| Gulletta, M | 1 |
| Ciravolo, G | 1 |
| Tedoldi, S | 1 |
| Casalini, C | 1 |
| Carosi, G | 1 |
| Orlando, G | 1 |
| Fasolo, MM | 1 |
| Beretta, R | 1 |
| Merli, S | 1 |
| Cargnel, A | 1 |
| Maiello, A | 1 |
| Racca, D | 1 |
| Zeme, DA | 1 |
| Quario, M | 1 |
| Sinicco, A | 1 |
| Di Perri, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Prospective, With One Site, Open-label Not Controled Trial, for the Observation of Treatment With CIDOFOVIR 1%, 3 Nights Per Week, During 4 Weeks, of Anal Intraepithelial Neoplasia, High Level, in HIV+ Patients[NCT01946009] | 20 participants (Actual) | Interventional | 2013-09-30 | Completed | |||
| Efficacy and Safety of Topical Trichloroacetic Acid vs. Electrocautery for the Treatment of Anal Intraepithelial Neoplasia in HIV-positive Patients (TECAIN) - a Randomized Controlled Trial[NCT02615860] | 560 participants (Actual) | Interventional | 2015-11-30 | Completed | |||
| A Pilot Study of the Effect of Cidofovir for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) in Subjects With Acquired Immunodeficiency Syndrome (AIDS)[NCT00000945] | 24 participants | Interventional | Completed | ||||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
10 reviews available for cytosine and HIV Coinfection
| Article | Year |
|---|---|
Use of cidofovir in a patient with severe mpox and uncontrolled HIV infection.
Topics: Antiviral Agents; Cidofovir; Cytosine; HIV Infections; Humans; Male; Middle Aged; Mpox (monkeypox); | 2023 |
Treatment options for progressive multifocal leukoencephalopathy in HIV-infected persons: current status and future directions.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cidofovir; Coinfection; Cy | 2016 |
Novel treatment of atypical human papillomavirus-associated epithelial hyperplasia with cidofovir.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Anus Neoplasms; Cidofovir; Cytosine; Epithe | 2011 |
The clinical potential of the acyclic (and cyclic) nucleoside phosphonates: the magic of the phosphonate bond.
Topics: Adenine; Antineoplastic Agents; Antiviral Agents; Cidofovir; Cytosine; Guanosine; Hepatitis B; HIV I | 2011 |
5-azacytosine compounds in medicinal chemistry: current stage and future perspectives.
Topics: Animals; Anti-HIV Agents; Antineoplastic Agents; Azacitidine; Cytosine; DNA Methylation; Drug Discov | 2012 |
Treatment options for anal intraepithelial neoplasia and evidence for their effectiveness.
Topics: Adult; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Anus Neoplasms; Cido | 2012 |
Progressive vaccinia.
Topics: Antiviral Agents; Cidofovir; Cytosine; HIV Infections; Humans; Methisazone; Organophosphonates; Orga | 2003 |
Management of cytomegalovirus disease.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Therapy, Combination; Foscar | 1995 |
Cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ga | 1999 |
Therapeutic potential of phosphonylmethoxyalkylpurines and -pyrimidines as antiviral agents.
Topics: Adenine; Animals; Antiviral Agents; Cidofovir; Cytosine; HIV Infections; Humans; Organophosphonates; | 1990 |
12 trials available for cytosine and HIV Coinfection
| Article | Year |
|---|---|
Predicted antiviral activity of tenofovir versus abacavir in combination with a cytosine analogue and the integrase inhibitor dolutegravir in HIV-1-infected South African patients initiating or failing first-line ART.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cytosine; Dideoxynucleosides; Drug Co | 2019 |
Topical cidofovir to treat high-grade anal intraepithelial neoplasia in HIV-infected patients: a pilot clinical trial.
Topics: Administration, Topical; Adult; Antiviral Agents; Anus Neoplasms; Biopsy; Carcinoma in Situ; Cidofov | 2016 |
A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS.
Topics: Adult; Antiviral Agents; Brain; Cerebrospinal Fluid; Cidofovir; Cytosine; HIV Infections; Humans; JC | 2002 |
[Treatment of cutaneous human papilloma virus, poxvirus and herpes simplex virus infections with topical cidofovir in HIV positive patients].
Topics: Administration, Topical; Adult; Antiviral Agents; Cidofovir; Cytosine; Female; Herpes Simplex; HIV I | 2004 |
The GNB3 C825T polymorphism affects response to HCV therapy with pegylated interferon in HCV/HIV co-infected but not in HCV mono-infected patients.
Topics: Adult; Aged; Antiviral Agents; Cytosine; Drug Therapy, Combination; Female; Genotype; GTP-Binding Pr | 2007 |
Susceptibility of human cytomegalovirus to cidofovir is unchanged after limited in vivo exposure to various regimens of drug.
Topics: Adult; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; | 1996 |
Pharmacokinetics, safety and bioavailability of HPMPC (cidofovir) in human immunodeficiency virus-infected subjects.
Topics: Adolescent; Adult; Antiviral Agents; Biological Availability; Cidofovir; Cytosine; Double-Blind Meth | 1996 |
Clinical pharmacokinetics of 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine in human immunodeficiency virus-infected patients.
Topics: Administration, Oral; Adult; Anti-HIV Agents; Biological Availability; Cidofovir; Cytosine; Female; | 1999 |
Oxidative DNA base damage in lymphocytes of HIV-infected drug users.
Topics: Adenine; Adolescent; Adult; Chromatin; Cytosine; DNA Damage; Guanine; HIV Infections; Humans; Lympho | 1999 |
Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cerebrospinal F | 2000 |
Efficacy and tolerability of topical 1% cidofovir cream for the treatment of external anogenital warts in HIV-infected persons.
Topics: Administration, Cutaneous; Adult; Antiviral Agents; Anus Diseases; Cidofovir; Cytosine; Female; Fema | 2001 |
Combined surgery and cidofovir is an effective treatment for genital warts in HIV-infected patients.
Topics: Adult; Antiviral Agents; Cidofovir; Combined Modality Therapy; Condylomata Acuminata; Cytosine; Elec | 2002 |
40 other studies available for cytosine and HIV Coinfection
| Article | Year |
|---|---|
Synthesis and Antiviral Evaluation of 3'-Fluoro-5'-norcarbocyclic Nucleoside Phosphonates Bearing Uracil and Cytosine as Potential Antiviral Agents.
Topics: Anti-HIV Agents; Cytosine; HIV Infections; HIV-1; Humans; Nucleosides; Organophosphonates; Structure | 2020 |
Human papillomavirus: the fundamentals of HPV for oral health care providers.
Topics: Antiviral Agents; Cidofovir; Cytosine; HIV Infections; Humans; Mouth Neoplasms; Organophosphonates; | 2013 |
Intralesional cidofovir for treating extensive genital verrucous herpes simplex virus infection.
Topics: Antiviral Agents; Cidofovir; Coinfection; Cytosine; Hepatitis C; Herpes Genitalis; HIV Infections; H | 2013 |
Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; Drug | 2014 |
Exonuclease III-based target recycling for ultrasensitive homogeneous monitoring of HIV DNA using Ag(+)-coordinated hairpin probe.
Topics: Base Sequence; Biosensing Techniques; Coordination Complexes; Cytosine; DNA Probes; DNA, Viral; Elec | 2015 |
Topical cidofovir for severe warts in a patient affected by AIDS and Hodgkin's lymphoma.
Topics: Administration, Topical; Adult; Antiviral Agents; Cidofovir; Cytosine; Foot; Hand; HIV Infections; H | 2008 |
Efficacy of intravenous cidofovir in the treatment of giant molluscum contagiosum in a patient with human immunodeficiency virus.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cidofovir; Cyto | 2011 |
Recalcitrant herpetic scrotal ulcer as a manifestation of immune reconstitution inflammatory syndrome.
Topics: Administration, Topical; Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Biopsy, Nee | 2011 |
Treatment of anal intraepithelial neoplasia: has it come of age?
Topics: Antiviral Agents; Anus Neoplasms; Carcinoma in Situ; Cidofovir; Cytosine; Female; HIV Infections; Hu | 2013 |
Cidofovir and surgery for genital warts.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Combined Modality Therapy; Condylomata Acu | 2002 |
Progressive multifocal leukoencephalopathy successfully treated with highly active antiretroviral therapy and cidofovir in an adolescent infected with perinatal human immunodeficiency virus (HIV).
Topics: Adolescent; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral | 2004 |
The management of oral human papillomavirus with topical cidofovir: a case report.
Topics: Administration, Topical; Adult; Antiviral Agents; Cidofovir; Cytosine; Diagnosis, Differential; Gels | 2004 |
Failure of cidofovir in HIV-associated multicentric Castleman disease.
Topics: Anti-HIV Agents; Castleman Disease; Cidofovir; Cytosine; HIV Infections; Humans; Organophosphonates; | 2004 |
Impaired base excision repair and accumulation of oxidative base lesions in CD4+ T cells of HIV-infected patients.
Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; CD | 2005 |
HIV-1-associated uracil DNA glycosylase activity controls dUTP misincorporation in viral DNA and is essential to the HIV-1 life cycle.
Topics: Base Sequence; Cytosine; Deamination; Deoxyuracil Nucleotides; DNA Glycosylases; DNA, Viral; Gene Pr | 2005 |
Tubular cell apoptosis and cidofovir-induced acute renal failure.
Topics: Acute Kidney Injury; Adult; Annexin A5; Antiviral Agents; Apoptosis; Caspase 3; Caspases; Cells, Cul | 2005 |
Fatal HHV-6 associated encephalitis in an HIV-1 infected patient treated with cidofovir.
Topics: Antiviral Agents; Biopsy; Brain; Cidofovir; Cytosine; Encephalitis, Viral; Fatal Outcome; Female; He | 2006 |
Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines.
Topics: Adenoviridae; Adenoviridae Infections; Animals; Anti-HIV Agents; Antiviral Agents; Cell Line; Cidofo | 2005 |
[Pure alexia secondary to progressive multifocal leukoencephalopathy as first manifestation of HIV infection].
Topics: Alexia, Pure; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Brain; Cidofovir; Cytosine; HI | 2006 |
Chronic hypertrophic acyclovir-resistant genital herpes treated with topical cidofovir and with topical foscarnet at recurrence in an HIV-positive man.
Topics: Acyclovir; Administration, Topical; Antiretroviral Therapy, Highly Active; Antiviral Agents; Chronic | 2006 |
Human immunodeficiency virus-associated progressive multifocal leucoencephalopathy: epidemiology and predictive factors for prolonged survival.
Topics: Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cidofovir | 2007 |
Interleukin-10 gene (IL10) polymorphisms and human papillomavirus clearance among immunosuppressed adolescents.
Topics: Adolescent; Adult; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Child; Cohort Studies; Cytosine | 2007 |
[Resolution of recalcitrant condyloma acuminata in a patient with human immunodeficiency virus treated with cidofovir].
Topics: Adult; Antiviral Agents; Cidofovir; Condylomata Acuminata; Cytosine; HIV Infections; Humans; Male; O | 2008 |
[Extensive oral condylomas treated by in situ cidofovir injection in an HIV patient].
Topics: Adult; Antiviral Agents; Cidofovir; Condylomata Acuminata; Cytosine; HIV Infections; Humans; Injecti | 2008 |
Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infection | 1995 |
Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria.
Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; HIV Infections; Humans; Ma | 1995 |
More new drugs for HIV and associated infections.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antiviral Agents; Cido | 1997 |
Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with cidofovir.
Topics: Adult; Antiviral Agents; Cidofovir; Cytosine; HIV Infections; Humans; Male; Molluscum Contagiosum; O | 1997 |
New treatments for progressive multifocal leukoencephalopathy in HIV-1-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cidofovir; Cytosine; Drug Therapy, Co | 1998 |
Progressive multifocal leukoencephalopathy treated with cidofovir in HIV-infected patients receiving highly active anti-retroviral therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agent | 2000 |
Severe irreversible proximal renal tubular acidosis and azotaemia secondary to cidofovir.
Topics: Acidosis, Renal Tubular; Adult; Anti-HIV Agents; Cidofovir; Cytosine; HIV Infections; Humans; Male; | 2000 |
Failure of cidofovir therapy in progressive multifocal leukoencephalopathy unrelated to human immunodeficiency virus.
Topics: Anti-HIV Agents; Brain; Cidofovir; Cytosine; Female; HIV Infections; Humans; Leukoencephalopathy, Pr | 2001 |
Resolution of recalcitrant human papillomavirus gingival infection with topical cidofovir.
Topics: Anti-Infective Agents, Local; Antiviral Agents; Cidofovir; Cytosine; Gingival Diseases; HIV Infectio | 2000 |
Topical cidofovir for bowenoid papulosis in an HIV-infected patient.
Topics: Adult; Antineoplastic Agents; Antiviral Agents; Anus Neoplasms; Carcinoma in Situ; Carcinoma, Squamo | 2001 |
Anti-HIV agents at ICAAC.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalo | 1996 |
Progressive multifocal leukoencephalopathy (PML).
Topics: AIDS-Related Opportunistic Infections; Antimetabolites, Antineoplastic; Antiviral Agents; Clinical T | 1998 |
A rocky road for nucleotide analogs.
Topics: Adenine; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Clinical Trials as Topi | 1998 |
Neurology update.
Topics: AIDS Dementia Complex; Anti-HIV Agents; Antiviral Agents; Brain; Cerebrospinal Fluid; Chicago; Cidof | 1999 |
Cidofovir for KS lesions.
Topics: Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cytosine; | 2001 |
A case of flare syndrome.
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; | 2001 |